COMPANY OVERVIEW

Neurelis, Inc. is a privately-held San Diego-based specialty pharmaceutical company organized to license, develop, and commercialize product candidates for epilepsy and the broader central nervous system (CNS) market.

---

LOCATION

San Diego, CA, USA

---

THERAPEUTIC AREAS

Neurological DIsorders

---

WEBSITE

https://www.neurelis.com/

---

CAREER WEBSITE

https://www.neurelis.com/careers

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Aug 31, 2023

NEURELIS TO PRESENT ANALYSES OF VALTOCO (diazepam nasal spray) CIV HIGHLIGHTING EFFECTS ON TIMING OF SEIZURES AT THE 35TH INTERNATIONAL EPILEPSY CONGRESS

May 15, 2023

NEURELIS ANNOUNCES NEW ROLES FOR TOP EXECUTIVES TO ADVANCE CLINICAL AND STRATEGIC INITIATIVES AND POSITION FOR FUTURE GROWTH

Apr 25, 2023

NEURELIS ANNOUNCES FOUR POSTER PRESENTATIONS AT THE 75TH ANNUAL MEETING OF THE AMERICAN ACADEMY OF NEUROLOGY

Mar 24, 2023

NEURELIS ANNOUNCES FIRST HEALTHY SUBJECTS DOSED IN INVESTIGATIONAL STUDY OF NRL-1049, A RHO KINASE (ROCK) INHIBITOR WITH POTENTIAL TO TREAT CEREBRAL CAVERNOUS MALFORMATIONS

Mar 2, 2023

NEURELIS WINS 2023 PM360 PHARMA CHOICE MULTICHANNEL GOLD AWARD FOR 'GIVE SEIZURES THE SPRAYER' MARKETING CAMPAIGN

For More Press Releases

---